chapter 10 Flashcards

1
Q

What is the primary action of drugs in pharmacology?

A

Drugs modulate existing physiological, biochemical, or biological processes within the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two main branches of pharmacology?

A
  • Pharmacodynamics
  • Pharmacokinetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define pharmacodynamics.

A

Studies how drugs affect the body through biochemical and physiological mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define pharmacokinetics.

A

Examines how the body handles drugs through absorption, distribution, metabolism, and excretion (ADME).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does pharmacotherapeutics focus on?

A

The clinical application of drugs to prevent and treat diseases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the difference between nonprescription (OTC) drugs and prescription drugs?

A
  • OTC drugs are available without a prescription and approved for safety and efficacy.
  • Prescription drugs require a prescription and are used for more serious conditions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a chemical name in drug nomenclature?

A

An accurate and detailed chemical description of the drug’s molecular structure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a generic (nonproprietary) name?

A

A simpler, officially recognized name for the drug, used in scientific literature.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the role of the liver in drug metabolism?

A

The liver converts drugs into more water-soluble forms for elimination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is biotransformation?

A

The process of metabolizing drugs to prepare them for elimination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the phases of biotransformation?

A
  • Phase I: Involves conversion into more ionized molecules.
  • Phase II: Involves synthetic reactions introducing new compounds.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the therapeutic index (TI)?

A

A measure of a drug’s safety calculated as the ratio between the toxic dose and the therapeutic dose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fill in the blank: The _______ is the primary organ responsible for drug elimination.

A

[kidneys]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What factors influence drug absorption?

A
  • Surface Area
  • Rate of Dissolution
  • Lipid Solubility
  • Blood Flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is acute toxicity?

A

Effects that occur within minutes or hours after exposure to a drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the first-pass effect?

A

Biotransformation after oral administration but before entering general circulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the key parameters for measuring time response in pharmacology?

A
  • Time of Drug Administration
  • Onset of Time Response
  • Cessation of Drug Effect
  • Peak Effect Time
  • Duration of Action Time
  • Latency to Effect Time
  • Threshold Level
18
Q

What is the role of pharmacy in pharmacology?

A

Involves preparation, compounding, dispensing, and documentation of medications.

19
Q

What is the significance of the blood-brain barrier?

A

It poses an obstacle to drug entry into the brain.

20
Q

What are the different routes of drug administration for local action?

A
  • Topical Application
  • Mucous Membranes
  • Oral Administration
  • Inhalation
  • Iontophoresis
21
Q

What is subacute toxicity?

A

Effects that occur after repeated exposures for days to a drug.

22
Q

What are the schedules of controlled substances?

A
  • Schedule I: High abuse potential, no therapeutic use
  • Schedule II: High abuse potential, accepted for therapeutic use
  • Schedule III: Less potential for abuse, accepted for treatment
  • Schedule IV: Lower potential for abuse, reduced dependency
  • Schedule V: Lowest potential for abuse or dependency
23
Q

What is chronic toxicity?

A

Effects that occur over months to years with exposure exceeding elimination.

24
Q

What is the purpose of post-marketing monitoring?

A

Ongoing safety surveillance after a drug is released for general use.

25
What factors contribute to variability in drug responses?
* Toxic Effects * Liver & Kidney Disease * Starvation * Age * Genetics * Gender Factor * Species Variability * Circadian Rhythms
26
What is Schedule I in the context of controlled substances?
Drugs with high probability of abuse and no therapeutic use ## Footnote Schedule I substances are considered the most dangerous and are not accepted for medical use.
27
What characterizes Schedule II drugs?
Drugs with high probability of abuse but accepted for therapeutic use ## Footnote These drugs are available by prescription but are highly regulated.
28
What is the defining feature of Schedule III drugs?
Drugs with less potential for abuse; therapeutic drugs accepted for treatment in U.S. ## Footnote These drugs have a lower potential for dependency compared to Schedule I and II.
29
What does Schedule IV indicate about a drug?
Drugs in use in U.S. with lower potential for abuse than Schedule III; reduced potential for dependency ## Footnote These drugs are still controlled but are less strictly regulated.
30
What does Schedule V encompass?
Drugs in use in U.S. with lower potential for abuse or dependency than Schedule IV ## Footnote These drugs can often be obtained without a prescription in some states.
31
What is the purpose of scheduling controlled substances?
It reflects their potential for abuse and dependence; dictates regulations governing their manufacture, distribution, and use ## Footnote This classification helps ensure safety in drug use.
32
What are orphan drugs?
Medications developed to treat rare diseases ## Footnote These drugs often have limited commercial viability due to the small number of patients.
33
What is the threshold number of patients for a disease to be considered for orphan drug development?
200,000 or less ## Footnote This small patient population makes it less attractive for pharmaceutical companies without incentives.
34
What is an Investigational New Drug (IND) application?
A submission to the FDA before conducting clinical trials on humans ## Footnote It includes detailed information about the drug, proposed studies, and safety data.
35
What does the FDA review in an IND application?
To ensure the proposed studies are safe and ethical ## Footnote This review is crucial for the protection of trial participants.
36
What are experimental drugs?
Compounds that are still being researched and have not yet been approved by regulatory agencies like the FDA ## Footnote These drugs undergo extensive testing before they can be marketed.
37
What is the first phase in the research of experimental drugs?
Research Phase: Compounds undergo initial laboratory testing to determine potential effectiveness ## Footnote This phase is critical for assessing whether a drug should move to clinical trials.
38
What happens during the Clinical Trials phase?
These drugs are used in clinical trials to evaluate their effectiveness and safety ## Footnote Clinical trials are essential for determining if the drug can be safely marketed.
39
What is the purpose of monitoring in the experimental drug process?
Researchers closely monitor these drugs' performance and side effects ## Footnote This monitoring helps determine the drug's potential benefits and risks.
40
What occurs during the Regulatory Review phase?
Results are submitted to agencies like the FDA for approval consideration ## Footnote This phase determines whether the drug can be made available to the public.